Arovella Therapeutics ASX: ALA

📍 Melbourne, Australia👥 24 employees
Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Arovella Therapeutics ASX: ALA in?
Arovella Therapeutics ASX: ALA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arovella Therapeutics ASX: ALA based?
Arovella Therapeutics ASX: ALA is headquartered in Melbourne, Australia.